Biological therapy in the reduction of cardiovascular risk in patients with psoriasis
Psoriasis is a chronic inflammatory disease that primarily affects the skin, and its complications include a predisposition to atherosclerosis and cardiovascular disease (CVD), with this risk related to the severity of psoriasis. The mechanisms by which psoriasis predisposes to CVD are not clear. Th...
Saved in:
| Main Author: | Andrés Tirado-Sánchez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Permanyer
2025-01-01
|
| Series: | Revista Médica del Hospital General de México |
| Subjects: | |
| Online Access: | https://www.hospitalgeneral.mx/frame_eng.php?id=242 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biologic Therapy and Cardiometabolic Risk in Psoriasis: A Retrospective Review
by: Annika Smith, et al.
Published: (2025-01-01) -
New Therapies in the Biological Treatment of Psoriasis: A Review
by: Mateusz Kamil Ożóg, et al.
Published: (2025-06-01) -
Cutaneous Changes Beyond Psoriasis: The Impact of Biologic Therapies on Angiomas and Solar Lentigines
by: Florin Ciprian Bujoreanu, et al.
Published: (2025-03-01) -
IMPACT OF BIOLOGICAL THERAPY ON BONE IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: P. S. Dydykina, et al.
Published: (2014-12-01) -
Dual Biologic Therapy for Psoriasis in a Patient with Atopic Dermatitis
by: Ma L, et al.
Published: (2025-04-01)